
### [NCIT:C9145](http://purl.obolibrary.org/obo/NCIT_C9145)
**Label:** Osteosarcoma

**Subclasses:** [NCIT:C6615](http://purl.obolibrary.org/obo/NCIT_C6615) (Mediastinal Extraskeletal Osteosarcoma), [NCIT:C27376](http://purl.obolibrary.org/obo/NCIT_C27376) (Childhood Extraskeletal Osteosarcoma), [NCIT:C4834](http://purl.obolibrary.org/obo/NCIT_C4834) (Primary Bone Osteosarcoma), [NCIT:C7925](http://purl.obolibrary.org/obo/NCIT_C7925) (Adult Extraskeletal Osteosarcoma), [NCIT:C6710](http://purl.obolibrary.org/obo/NCIT_C6710) (Stage II Osteosarcoma  AJCC v7), [NCIT:C8810](http://purl.obolibrary.org/obo/NCIT_C8810) (Extraskeletal Osteosarcoma), [NCIT:C8811](http://purl.obolibrary.org/obo/NCIT_C8811) (Recurrent Extraskeletal Osteosarcoma), [NCIT:C136633](http://purl.obolibrary.org/obo/NCIT_C136633) (Osteosarcoma by AJCC v7 Stage), [NCIT:C6612](http://purl.obolibrary.org/obo/NCIT_C6612) (Stage III Osteosarcoma  AJCC v7), [NCIT:C7002](http://purl.obolibrary.org/obo/NCIT_C7002) (Central Nervous System Extraskeletal Osteosarcoma), [NCIT:C5189](http://purl.obolibrary.org/obo/NCIT_C5189) (Breast Extraskeletal Osteosarcoma), [NCIT:C7780](http://purl.obolibrary.org/obo/NCIT_C7780) (Localized Osteosarcoma), [NCIT:C6470](http://purl.obolibrary.org/obo/NCIT_C6470) (Multifocal Osteosarcoma), [NCIT:C8970](http://purl.obolibrary.org/obo/NCIT_C8970) (Periosteal Osteosarcoma), [NCIT:C7881](http://purl.obolibrary.org/obo/NCIT_C7881) (Recurrent Osteosarcoma), [NCIT:C7781](http://purl.obolibrary.org/obo/NCIT_C7781) (Metastatic Osteosarcoma), [NCIT:C6181](http://purl.obolibrary.org/obo/NCIT_C6181) (Kidney Extraskeletal Osteosarcoma), [NCIT:C35870](http://purl.obolibrary.org/obo/NCIT_C35870) (Conventional Osteosarcoma), [NCIT:C123398](http://purl.obolibrary.org/obo/NCIT_C123398) (Childhood Periosteal Osteosarcoma), [NCIT:C53706](http://purl.obolibrary.org/obo/NCIT_C53706) (Radiation-Related Osteosarcoma), [NCIT:C53707](http://purl.obolibrary.org/obo/NCIT_C53707) (Bone Osteosarcoma), [NCIT:C53704](http://purl.obolibrary.org/obo/NCIT_C53704) (Secondary Osteosarcoma), [NCIT:C5833](http://purl.obolibrary.org/obo/NCIT_C5833) (Liver Extraskeletal Osteosarcoma), [NCIT:C8969](http://purl.obolibrary.org/obo/NCIT_C8969) (Parosteal Osteosarcoma), [NCIT:C6589](http://purl.obolibrary.org/obo/NCIT_C6589) (Childhood Parosteal Osteosarcoma), [NCIT:C6701](http://purl.obolibrary.org/obo/NCIT_C6701) (Stage IV Osteosarcoma  AJCC v7), [NCIT:C6469](http://purl.obolibrary.org/obo/NCIT_C6469) (Osteosarcoma Arising in Paget Disease of Bone), [NCIT:C6585](http://purl.obolibrary.org/obo/NCIT_C6585) (Childhood Osteosarcoma), [NCIT:C4021](http://purl.obolibrary.org/obo/NCIT_C4021) (Chondroblastic Osteosarcoma), [NCIT:C82972](http://purl.obolibrary.org/obo/NCIT_C82972) (Duodenal Extraskeletal Osteosarcoma), [NCIT:C7134](http://purl.obolibrary.org/obo/NCIT_C7134) (Bone Surface (Peripheral) Osteosarcoma), [NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma), [NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma), [NCIT:C6590](http://purl.obolibrary.org/obo/NCIT_C6590) (Childhood Conventional Osteosarcoma), [NCIT:C53958](http://purl.obolibrary.org/obo/NCIT_C53958) (High Grade Surface Osteosarcoma), [NCIT:C53953](http://purl.obolibrary.org/obo/NCIT_C53953) (Osteoblastic Osteosarcoma), [NCIT:C6709](http://purl.obolibrary.org/obo/NCIT_C6709) (Stage I Osteosarcoma  AJCC v7), [NCIT:C8808](http://purl.obolibrary.org/obo/NCIT_C8808) (Metastatic Extraskeletal Osteosarcoma), 

**Class expressions from DL-Learner:**

- [CL:0000062](http://purl.obolibrary.org/obo/CL_0000062) (osteoblast) 53.57%
- Thing 53.00%
- [NCIT:C36900](http://purl.obolibrary.org/obo/NCIT_C36900) (Neoplastic Osteoblast) 42.50%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 38.93%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 38.93%


